Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups

Clinical Microbiology and Infection

Volumn 14, Issue 3, 2008, Pages 260-267

  Zhao, Z ^a   Kong, F ^b   Zeng, X ^c   Gidding, H F ^b   Morgan, J ^d   Gilbert, G L ^b  

^a PEKING UNIVERSITY   (China)

^b WESTMEAD HOSPITAL   (Australia)

^c Wuhan Pulmonary Hospital   (China)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Antibiotic resistance; Distribution; Group B streptococci; MPCR RLB; Serotypes; Streptococcus agalactiae

Indexed keywords

AMINOGLYCOSIDE; ERYTHROMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA AND NEW ZEALAND; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HYBRIDIZATION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 38849108072     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01914.x     Document Type: Article

References (36)

1. Schuchat A. Group.B streptococcus. Lancet 1999; 353: 51-56.
2. Schuchat A. Epidemiology of group.B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
3. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3: 201-213.
4. Paoletti LC, Madoff LC. Vaccines to prevent neonatal GBS infection. Semin Neonatol 2002; 7: 315-323.
5. Harrison LH, Elliott JA, Dwyer DM et al. Serotype distribution of invasive group.B streptococcal isolates in Maryland: Implications for vaccine formulation. J Infect Dis 1998; 177: 998-1002.
6. Kong F, Ma L, Gilbert GL. Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. J Med Microbiol 2005; 54: 1133-1138.
7. Zeng X, Kong F, Wang H, Darbar A, Gilbert GL. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother 2006; 50: 204-209.
8. Kong F, Martin D, James G, Gilbert GL. Towards a genotyping system for Streptococcus agalactiae (group.B streptococcus): Use of mobile genetic elements in Australasian invasive isolates. J Med Microbiol 2003; 52: 337-344.
9. Schuchat A, Wenger JD. Epidemiology of group.B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994; 16: 374-402.
10. Kong F, Gilbert GL. Using cpsA-cpsB sequence polymorphisms and serotype-/ group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J Med Microbiol 2003; 52: 1047-1058.
11. Jones N, Bohnsack JF, Takahashi S et al. Multilocus sequence typing system for group.B Streptococcus. J Clin Microbiol 2003; 41: 2530-2536.
12. Sun Y, Kong F, Zhao Z, Gilbert GL. Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (Group.B Streptococcus). J Clin Microbiol 2005; 43: 4704-4707.
13. Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M. Multilocus sequence typing of Swedish invasive group.B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 2005; 43: 3727-3733.
14. Takahashi S, Adderson EE, Nagano Y, Nagano N, Briesacher MR, Bohnsack JF. Identification of a highly encapsulated, genetically related group of invasive type.III group.B streptococci. J Infect Dis 1998; 177: 1116-1119.
15. Bohnsack JF, Whiting AA, Bradford RD, Van Frank BK, Takahashi S, Adderson EE. Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type.III-3 reveals clustering of virulence genes. Infect Immun 2002; 70: 134-139.
16. Adderson EE, Takahashi S, Wang Y, Armstrong J, Miller DV, Bohnsack JF. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype.III group.B Streptococcus agalactiae. Infect Immun 2003; 71: 6857-6863.
17. Fleming KE, Bohnsack JF, Palacios GC, Takahashi S, Adderson EE. Equivalence of high-virulence clonotypes of serotype.III group.B Streptococcus agalactiae (GBS). J Med Microbiol 2004; 53: 505-508.
18. Jones N, Oliver KA, Barry J et al. Enhanced invasiveness of bovine-derived neonatal sequence type.17 group.B Streptococcus is independent of capsular serotype. Clin Infect Dis 2006; 42: 915-924.
19. Kong F, Gowan S, Martin D, James G, Gilbert GL. Serotype identification of group. B streptococci (GBS) with PCR and sequencing. J Clin Microbiol 2002; 40: 216-226.
20. Grimwood K, Darlow BA, Gosling IA et al. Early-onset neonatal group.B streptococcal infections in New Zealand 1998-1999. J Paediatr Child Health 2002; 38: 272-277.
21. Stylianopoulos A, Kelly N, Garland S. Is penicillin and/or erythromycin resistance present in clinical isolates of group.B streptococcus in our community? Aust NZ J Obstet Gynaecol 2002; 42: 543-544.
22. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group.B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001; 45: 3504-3508.
23. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. Streptococcus agalactiae in a large Portuguese teaching hospital: Antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 2004; 10: 31-36.
24. Ko WC, Lee HC, Wang LR, Lee CT, Liu AJ, Wu JJ. Serotyping and antimicrobial susceptibility of group. B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis 2001; 20: 334-339.
25. Diekema DJ, Andrews JI, Huynh H et al. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group. B streptococci. J Clin Microbiol 2003; 41: 2659-2661.
26. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group. B streptococcus isolated from pregnant women. Obstet Gynecol 2003; 101: 74-79.
27. Desjardins M, Delgaty KL, Ramotar K, Seetaram C, Toye B. Prevalence and mechanisms of erythromycin resistance in group.A and group.B streptococcus: Implications for reporting susceptibility results. J Clin Microbiol 2004; 42: 5620-5623.
28. Poyart C, Jardy L, Quesne G, Berche P, Trieu-Cuot P. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003; 47: 794-797.
29. Fitoussi F, Loukil C, Gros I et al. Mechanisms of macrolide resistance in clinical group. B streptococci isolated in France. Antimicrob Agents Chemother 2001; 45: 1889-1891.
30. De Mouy D, Cavallo JD, Leclercq R, Fabre R. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother 2001; 45: 2400-2402.
31. Aracil B, Minambres M, Oteo J, de la Rosa M, Gomez-Garces JL, Alos AJ. Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin Microbiol Infect 2002; 8: 745-748.
32. Betriu C, Culebras E, Gomez M et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 2003; 47: 1112-1114.
33. Wessels MR, Paoletti LC, Rodewald AK et al. Stimulation of protective antibodies against type.Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993; 61: 4760-4766.
34. Madoff LC, Michel JL, Gong EW, Rodewald AK, Kasper DL. Protection of neonatal mice from group. B streptococcal infection by maternal immunization with beta C protein. Infect Immun 1992; 60: 4989-4994.
35. Borchardt SM, Foxman B, Chaffin DO et al. Comparison of DNA dot blot hybridization and Lancefield capillary precipitin methods for group. B streptococcal capsular typing. J Clin Microbiol 2004; 42: 146-150.
36. Elliott JA, Thompson TA, Facklam RR, Slotved HC. Increased sensitivity of a latex agglutination method for serotyping group B streptococcus. J Clin Microbiol 2004; 42: 3907.